Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Abu, Alex"'
Autor:
Abu, Alex, Carrey, Raúl, Navarro-Ciurana, Dídac, Margalef-Marti, Rosanna, Soler, Albert, Otero, Neus, Domènech, Cristina
Publikováno v:
In Chemical Geology 5 March 2024 647
Autor:
Abu, Alex, Carrey, Raúl, Valhondo, Cristina, Domènech, Cristina, Soler, Albert, Martínez-Landa, Lurdes, Diaz-Cruz, Silvia, Carrera, Jesús, Otero, Neus
Publikováno v:
In Journal of Environmental Management 1 November 2022 321
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Uday Kulkarni, Saravanan Ganesan, Ansu Abu Alex, Hamenth Palani, Sachin David, Nithya Balasundaram, Arvind Venkatraman, Mani Thenmozhi, Lakshmanan Jeyaseelan, Anu Korula, Anup Devasia, Aby Abraham, Nancy Beryl Janet, Poonkuzhali Balasubramanian, Biju George, Vikram Mathews
Publikováno v:
Cancer Medicine, Vol 9, Iss 8, Pp 2603-2610 (2020)
Abstract The standard‐of‐care for patients with acute promyelocytic leukemia (APL) relapsing after upfront arsenic trioxide (ATO) therapy is not defined. The present study was undertaken to evaluate the safety of addition of bortezomib to ATO in
Externí odkaz:
https://doaj.org/article/7479df91ae71429881fbed1ef7615da6
Autor:
Punit Jain, Anu Korula, Prashant Deshpande, Nisham PN, Ansu Abu Alex, Aby Abraham, Alok Srivastava, Nancy Beryl Janet, Kavitha M. Lakshmi, Poonkuzhali Balasubramanian, Biju George, Vikram Mathews
Publikováno v:
Journal of Global Oncology, Vol 4, Iss 1, Pp 1-12 (2018)
Purpose: Limited data exist on intensifying chemotherapy regimens in the treatment of adult acute lymphoblastic leukemia (ALL) outside the setting of a clinical trial. Materials and Methods: Retrospectively, data from 507 consecutive adults (age ≥
Externí odkaz:
https://doaj.org/article/9e03d352c9ba4a03b06d77a5f72ec922
Autor:
Ezhilarasi Chendamarai, Swathy Palanikumar, Saravanan Ganesan, Nair Reeshma Radhakrishnan, Uday Kulkarni, Nithya Balasundaram, Mohammed Yasar M, Anu Korula, Ansu Abu Alex, Hamenth Kumar Palani, Sachin David, Poonkuzhali Balasubramanian, Sanjeev Krishna, Vikram Mathews, Arvind Venkatraman, Nancy Beryl Janet
Publikováno v:
Blood Advances
Key Points Metabolic rewiring promotes ATO resistance in APL, independent of PML mutation status.Inhibition of mitochondrial respiration combined with ATO is a potential therapeutic option for relapsed APL and non-M3 AML.
Visual Abstract
Ac
Visual Abstract
Ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccb796629895febc1d5e2179b9c6d5bc
https://doi.org/10.1182/bloodadvances.2021005300
https://doi.org/10.1182/bloodadvances.2021005300
Autor:
Ansu Abu Alex, Saravanan Ganesan, Hamenth Kumar Palani, Nithya Balasundaram, Sachin David, Kavitha M. Lakshmi, Uday P. Kulkarni, P. N. Nisham, Anu Korula, Anup J. Devasia, Nancy Beryl Janet, Aby Abraham, Alok Srivastava, Biju George, Rose Ann Padua, Christine Chomienne, Poonkuzhali Balasubramanian, Vikram Mathews
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Natural killer cells (NK) contribute significantly to eradication of cancer cells, and there is increased interest in strategies to enhance it’s efficacy. Therapeutic agents used in the treatment of cancer can impact the immune system in a quantita
Externí odkaz:
https://doaj.org/article/ebaf9823b20b4e3e92261a9c940f0f4c
Autor:
Abu, Alex, Domènech, Cristina, Carrey, Raúl, Navarro-Ciurana, Dídac, Otero, Neus, Causapé, Jesús
Poster presentation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b35419e5a91308f95b5c421ba9321ad8
Autor:
Ansu Abu Alex, Anu Korula, Nithya Balasundaram, Nancy Beryl Janet, Aby Abraham, Mani Thenmozhi, Saravanan Ganesan, Biju George, Hamenth Kumar Palani, Vikram Mathews, Sachin David, Lakshmanan Jeyaseelan, Anup J. Devasia, Arvind Venkatraman, Uday Kulkarni, Poonkuzhali Balasubramanian
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 8, Pp 2603-2610 (2020)
Cancer Medicine, Vol 9, Iss 8, Pp 2603-2610 (2020)
The standard‐of‐care for patients with acute promyelocytic leukemia (APL) relapsing after upfront arsenic trioxide (ATO) therapy is not defined. The present study was undertaken to evaluate the safety of addition of bortezomib to ATO in the treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e6ba12ba8e02373c0e733c2b3fcf693
https://doi.org/10.1002/cam4.2883
https://doi.org/10.1002/cam4.2883
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.